IP Library Granted Patent US 10,420,862
Granted Patent B2
US 10,420,862 · App. 13/532,013 · Granted Sep 24, 2019

In-situ forming foams for treatment of aneurysms

Inventors: Upma Sharma (Somerville, MA); Gregory Zugates (Chelmsford, MA); Rany Busold (Medford, MA); Toby Freyman (Waltham, MA)
Assignee: Aresenal AAA, LLC.
A61L31/146A61L31/06A61L31/14A61L31/141A61L31/18A61L2400/06A61L2430/36A61M25/007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,420,862
App. No.
13/532,013
Granted
Sep 24, 2019
Kind
B2
Abstract

Systems, methods and kits relating to in-situ forming polymer foams for the treatment of aneurysms are disclosed. The systems include an insertable medical device and an in-situ forming foam that is formed from a polymer that reacts in an aqueous environment. When used to treat an aneurysm, the foam is placed into contact with at least a portion of an exterior surface of the medical device and/or the tissue surface of the aneurysm.

Claims (26)

1. A method for treating an aneurysm within a patient, the aneurysm characterized by a first end, a second end, and a surface between the first and second ends, said method comprising the steps of:

placing a medical device within said aneurysm, said medical device comprising a structure having a first end, a second end, and an exterior surface between said first and second ends;

delivering, with a catheter, a material between the exterior surface of said medical device and the surface of the aneurysm; and

forming a foam from said material upon delivery between the exterior surface of said medical device and the surface of the aneurysm;

wherein (a) said foam is formed by the reaction of said material with blood in situ and (b) the reaction includes the generation of a gas, said gas expanding a portion of the material into an interstitial area.

2. The method of claim 1 , wherein said foam comprises polyurethane.

3. The method of claim 2 , wherein said polyurethane is a poly(urethane urea).

4. The method of claim 1 , wherein said foam is formed by the reaction of a multifunctional isocyanate and a polyol.

5. The method of claim 4 , wherein said isocyanate is at least one of hexamethylene diisocyanate, toluene diisocyanate, methylene diphenyl diisocyanate, lysine isocyanate, isophorone diisocyanate, and mixtures thereof.

6. The method of claim 4 , wherein said polyol is selected from the group consisting of polyethers and polybutadienes.

7. The method of claim 4 , wherein said multifunctional isocyanate and said polyol are delivered between the exterior surface of said medical device and the surface of the aneurysm as separate components to form said foam.

8. The method of claim 4 , wherein said multifunctional isocyanate and said polyol are delivered between the exterior surface of said medical device and the surface of the aneurysm as a mixture to form said foam.

9. The method of claim 1 , wherein said foam comprises a visualization material.

10. The method of claim 1 , wherein said foam further comprises at least one of a surfactant, a chain extender, a pore opener, a filler, a catalyst, a diluent, and a plasticizer.

11. The method of claim 1 , wherein said foam contacts said surface of said aneurysm.

12. The method of claim 1 , wherein said medical device comprises a graft.

13. The method of claim 1 , wherein said medical device comprises a stent-graft.

14. The method of claim 1 , wherein said medical device comprises a balloon.

15. The method of claim 1 , wherein said delivering step comprises the steps of:

placing a catheter between said first and second ends of said aneurysm; and

introducing said material through said catheter.

16. The method of claim 15 , wherein said catheter comprises a one-way valve.

17. The method of claim 1 , wherein the material is a fluid comprising a prepolymer.

18. The method of claim 1 , wherein the material is a fluid prepolymer.

19. The method of claim 1 , wherein the material comprises a polysiloxane.

20. The method of claim 19 , wherein the material comprises a multifunctional isocyanate and the gas is carbon dioxide.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2021
From: ARSENAL AAA, LLC
To: MEDTRONIC VASCULAR, INC.
Reel/Frame 057503/0059 →
NUNC PRO TUNC ASSIGNMENT Recorded Jan 29, 2019
From: ARSENAL MEDICAL, INC.
To: ARSENAL AAA, LLC.
Reel/Frame 048165/0932 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING AND THE NATURE OF CONVEYANCE PREVIOUSLY RECORDED AT REEL: 035855 FRAME: 0083. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Jan 22, 2016
From: ARSENAL AAA
To: MEDTRONIC, INC.
Reel/Frame 037629/0132 →
SECURITY INTEREST Recorded Nov 15, 2015
From: ARSENAL AAA, LLC
To: MEDTRONIC, INC.
Reel/Frame 037041/0947 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2015
From: ARSENAL AAA, LLC
To: MEDTRONIC, INC.
Reel/Frame 035855/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2012
From: SHARMA, UPMA; ZUGATES, GREGORY; BUSOLD, RANY; FREYMAN, TOBY
To: ARSENAL MEDICAL, INC.
Reel/Frame 028573/0372 →
Continuity (6)
Continuation In Part 13209020 · Aug 12, 2011
Continuation In Part 12862362 · Aug 24, 2010
Provisional Application 61236314 · Aug 24, 2009
Provisional Application 61368095 · Jul 27, 2010
Provisional Application 61601151 · Feb 21, 2012
Related Publication 20120265287A1 · Oct 18, 2012